Form 483

Fertility and Advanced Reproductive Medicine at UTSW Form 483, 2023-12-13

FDA issued a Form 483 to Fertility and Advanced Reproductive Medicine at UTSW on 2023-12-13 with 8 public-safe observations.

483· Form 483 issuedBiologics8 observations

Fertility and Advanced Reproductive Medicine at UTSW · Dallas, United States · Issued December 13, 2023

Overview

  • 8 public-safe observations are available for this inspection.
  • 4 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

13 Dec 2023
21 CFR 1271.50(b)(2)

Donor testing not negative for CD agents

Cited by Bobbi J Miller, Ramon L Gonzalez-Prieto

13 Dec 2023
21 CFR 1271.50(b)(2)

Donor testing not negative for CD agents

Cited by Bobbi J Miller, Ramon L Gonzalez-Prieto

13 Dec 2023
21 CFR 1271.55(d)(1)(iii)

Documentation--determination, by whom, date

Cited by Bobbi J Miller, Ramon L Gonzalez-Prieto

13 Dec 2023
21 CFR 1271.55(d)(1)(iii)

Documentation--determination, by whom, date

Cited by Bobbi J Miller, Ramon L Gonzalez-Prieto

13 Dec 2023
21 CFR 1271.75(a)(1)

Risk factors, clinical evidence

Cited by Bobbi J Miller, Ramon L Gonzalez-Prieto

Inspected site

Inspection team

BJBobbi J Miller

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 1271.50(b)(2)Cited across public-safe Form 483 observations2x
21 CFR 1271.55(d)(1)(iii)Cited across public-safe Form 483 observations2x
21 CFR 1271.75(a)(1)Cited across public-safe Form 483 observations2x
21 CFR 1271.90(c)Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 8 observations

The source PDF, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere